Posted On: 11/22/2014 10:41:05 PM
Post# of 30066
Let's all guess what catalyst will bring money in for the trials about to kick off, Amarantus is not selling LymPro in the near future!
Following the in-depth analysis of the full 140-subject mild-to-severe AD cohort, Amarantus will then make a determination regarding which version of LymPro (Version 1 or Version 2) to launch under the CLIA designation for marketing to the broader medical community in the United States in 2015.
Following the in-depth analysis of the full 140-subject mild-to-severe AD cohort, Amarantus will then make a determination regarding which version of LymPro (Version 1 or Version 2) to launch under the CLIA designation for marketing to the broader medical community in the United States in 2015.
(0)
(0)
